OPPORTUNITIES & BARRIERS TO IMPLEMENTATION OF LONG-ACTING INJECTABLES FOR HIV TREATMENT AND PREVENTION

The goal of this survey is to learn about barriers to implementation of long-acting injectables for HIV treatment and prevention. This survey is being conducted by the HIV Medicine Association.

This is a one-time survey that will take approximately 10 minutes. There is no compensation for the survey, but your responses will help HIVMA identify issues to inform its advocacy and educational efforts to improve implementation of long-acting injectables for HIV treatment and prevention in the U.S.

Your participation is voluntary and confidential. Responses will be anonymous. You can choose not to answer any question and you can stop the survey at any time. If you have any questions about this survey, please contact HIVMA staff at info@hivma.org.

To participate, please start with the question below to determine if you are eligible to participate.

Question Title

* 1. Are you a health care provider working in HIV treatment or prevention? Health care providers include prescribers of HIV therapy and prevention as well as clinical and non-clinical support staff in clinical areas with a focus on HIV treatment or prevention.

Yes